Oncozine.com - SEO Checker

¡Registrarme gratis! Exportar PDF
Visión general del análisis SEO
Metadatos
80% 
Calidad de la página
64% 
Estructura
58% 
Enlazado
0% 
Servidor
86% 
Factores externos
100% 
Puntuación SEO
Tiempo de carga
1,01 s
Tamaño HTML
221,30 kB
Palabras
1884
Medios
8
Cantidad de enlaces
283 internos / 75 externos

Lista de tareas pendientes para mejorar tu SEO

Metadatos

Título
(Extremadamente importante)
Home - Onco'Zine - A part of the Oncology and Hematology News Network
Con 670 píxeles, el título de esta página es demasiado largo. Optimizar el título
No se repite ninguna palabra en el título.
Meta descripción
(Extremadamente importante)
Onco'Zine is part of the Oncology and Hematology News Network that has been created to better inform physicians treating patients with cancer
La longitud de la meta descripción es óptima (887 píxeles de una longitud máxima de 1000 píxeles).
Rastreabilidad
(Extremadamente importante)
No se detectan problemas para acceder al sitio web.
Redirección canónica
(Importante)
https://www.oncozine.com/
La página tiene una redirección canónica correcta.
Idioma
(Poco importante)
Idioma reconocido automáticamente en el contenido: en
Idioma declarado en el código HTML: en-us
Ubicación geográfica del servidor: Estados Unidos de América
El idioma ha sido correctamente declarado en el código HTML: en-us.
Enlaces Alternate/Hreflang
(Poco importante)
No se ha encontrado ningún enlace alternativo (alternate) en esta página.
Otras Metaetiquetas
(Poco importante)
No se detecta ninguna metaetiqueta de paginación rel next en la página.
No se detecta ninguna metaetiqueta de paginación rel prev en la página.
Dominio
(Poco importante)
El dominio no es un subdominio.
La longitud del nombre del dominio es buena.
El dominio no contiene caracteres especiales.
URL de la página
(Poco importante)
No se detecta ningún parámetro dinámico en la URL.
No se detecta ningún ID de sesión en la URL.
La URL no contiene demasiados subdirectorios.
Codificación de caracteres
(Poco importante)
La codificación de caracteres (UTF-8) ha sido declarada correctamente.
Doctype
(Deseable)
La etiqueta doctype HTML 5 está configurada correctamente.
La declaración del doctype se ubica al inicio del código HTML.
Favicon
(Deseable)
El favicon está enlazado correctamente.

Metaetiquetas

NombreValor
viewportwidth=device-width, initial-scale=1.0
robotsindex, follow, max-image-preview:large, max-snippet:-1, max-video-preview:-1
descriptionOnco'Zine is part of the Oncology and Hematology News Network that has been created to better inform physicians treating patients with cancer
msvalidate.01325DBF0B4415B7D5F77949B32086EEB2
google-site-verificationDvS50_-wX_jjHKRtegP7b3R6lPTOcwGV7N7mm1J2oAk
generatorWordPress 6.5.5
msapplication-TileImagehttps://www.oncozine.com/wp-content/uploads/2018/09/cropped-circle-270x270.png
article:publisherhttps://www.facebook.com/oncozine.journal
article:modified_time2023-11-14T01:28:40+00:00
langen-us
twitter:cardsummary_large_image
twitter:site@OncoZine
fb:pageshttps://www.facebook.com/OncoZine/
og:localeen_US
og:typewebsite
og:titleHome - Onco'Zine - A part of the Oncology and Hematology News Network
og:descriptionOnco'Zine is part of the Oncology and Hematology News Network that has been created to better inform physicians treating patients with cancer
og:urlhttps://www.oncozine.com/
og:site_nameOnco'Zine
charsetUTF-8

¡Analiza ya gratis hasta 1.000 páginas de oncozine.com!

Registrarme Gratis
Puedes usar la suscripción Básica por tiempo ilimitado.

Calidad de la página

Contenido
(Extremadamente importante)
Algunas palabras del título no se repiten en el cuerpo del texto.
Solo se han encontrado 1 párrafos en esta página.
En esta página hay faltas de ortografía:
  • advertisment => advertisement
El número total de palabras en la página es bueno: 1884 palabras.
Un 24.3% del contenido está constituido por palabras vacías.
Las palabras del encabezado H1 también aparecen en el cuerpo del texto.
La página contiene un listado, lo que indica una buena estructuración del contenido.
No se detecta ningún placeholder de texto ni imagen.
No se detecta contenido duplicado.
La cantidad media de palabras por frase es buena: 21 palabras.
Frames
(Extremadamente importante)
Esta página no utiliza ningún frameset.
Optimización para móviles
(Poco importante)
El valor de la etiqueta viewport es correcto: (width=device-width, initial-scale=1.0).
Al menos un icono de Apple-Touch ha sido especificado.
Etiquetas Bold y Strong
(Poco importante)
El uso de etiquetas de negritas en esta página es óptimo. Te recomendamos emplear hasta 38 etiquetas de negritas en una página.
Optimización de imágenes
(Poco importante)
No se detecta ninguna descripción del atributo ALT en 1 imágenes. El contenido de los atributos ALT también es evaluado como texto por los buscadores y es muy importante para la búsqueda de imágenes.
Redes Sociales
(Deseable)
Esta página apenas ofrece posibilidades de compartir el contenido en redes sociales. Con la integración de widgets puedes conseguir que tus contenidos se popularicen en redes.
Etiquetas markup adicionales
(Deseable)
No se detecta ninguna etiqueta markup (de Schema.org) adicional.
HTTPS
(Poco importante)
El sitio utiliza HTTPS para transferir datos de forma segura.
Todos los archivos incluidos se transfieren a través de HTTPS.

Lista de medios

URLAtributo ALTTítulo
...tent/uploads/2019/06/oncozine_270x90.pngOncoZine, The International Oncology NetworkOncoZine, The International Oncology Network
.../uploads/2019/06/oncozine-140x48_wht.pngOncoZine, The International Oncology NetworkOncoZine, The International Oncology Network
...tent/uploads/2019/06/oncozine_270x90.pngOncoZine, The International Oncology NetworkOncoZine, The International Oncology Network
...ads/2020/02/oncozine_brief-300x250-1.pngspot_img
...F4D-4F06-AB10-E80D755FFC56_4_5005_c.jpegspot_img
...ers-of-the-Cancer-Universe-300x250-1.jpgspot_img
.../uploads/2019/06/oncozine_270x90_wht.pngOnco\'Zine, The International Oncology NetworkOnco\'Zine, The International Oncology Network
...nt/uploads/2021/05/subcription-popup.pngCarece de atributo ALT

Estructura de la página

Encabezado H1
(Extremadamente importante)
Onco'Zine OncoZine, The International Oncology Network
El encabezado H1 es óptimo.
Encabezados
(Importante)
Algunos de los encabezados H se repiten dos veces.
En la estructura de los encabezados H faltan uno o varios niveles.
Hay 61 encabezados H en esta página. La cantidad de encabezados debería guardar una mejor proporción en relación al texto.

Estructura de los encabezados

Jerarquía de encabezadosContenido
H1 Onco'Zine OncoZine, The International Oncology Network
H3 Solutions to Identify Patients for Recruitment in Early Oncology Clinical Trials
H3 Crofelemer Reduces Diarrhea in Humans and Dogs Being Treated for Cancer, Recent Studies Show
H3 Study Shows New Co-Star Receptor to be Promising in Cancer Treatment
H3 The Concierge Catch: Better Access for a Few Patients Disrupts Care for Many
H3 ASCO 2024: Encouraging Dose Escalation Data from Ongoing Phase 1 KisMET-01 Study of MYTX-011
H3 Solutions to Identify Patients for Recruitment in Early Oncology Clinical Trials Texto duplicado
H3 Crofelemer Reduces Diarrhea in Humans and Dogs Being Treated for Cancer, Recent Studies Show Texto duplicado
H3 The Concierge Catch: Better Access for a Few Patients Disrupts Care for Many Texto duplicado
H3 The Transformative Potential of Exosome Research in Cancer Detection and Beyond
H3 A Global View of Oncology Informatics
H3 Standardizing Immunophenotyping Research Tools to Improve MDS and the Immune System
H3 Experts Forecast: Achieving Cancer Health Equity
H3 The Impact of DCISionRT Versus Clinicopathologic Factors Alone in Predicting Benefit of Radiation
H3 Solutions to Identify Patients for Recruitment in Early Oncology Clinical Trials Texto duplicado
H3 Crofelemer Reduces Diarrhea in Humans and Dogs Being Treated for Cancer, Recent Studies Show Texto duplicado
H3 Study Shows New Co-Star Receptor to be Promising in Cancer Treatment Texto duplicado
H3 The Concierge Catch: Better Access for a Few Patients Disrupts Care for Many Texto duplicado
H3 ASCO 2024: Encouraging Dose Escalation Data from Ongoing Phase 1 KisMET-01 Study of MYTX-011 Texto duplicado
H3 ASCO 2024: Adagrasib Shows Statistically Significant Improvement in PFS in KRASG12C-Mutated NSCLC
H3 ASCO 2024: A More Effective Treatment Combination for Hodgkin Lymphoma
H3 ASCO 2024: Asciminib – A Safer + More Effective Option for Newly Diagnosed Chronic...
H3 ASCO 2024: Durable Efficacy of Lorlatinib as a first-line choice in ALK-positive NSCLC n
H3 ASCO 2024: NATALEE shows Ribociclib Reduces Risk of Cancer Recurrence in Early Breast Cancer
H3 ASCO 2024: AbbVie to Showcases Robust Solid Tumor Pipeline with New Data from Its...
H3 Strong Immunology Portfolio helps Offset losses of AbbVie’s Adalimumab
H3 ASCO 2024: Encouraging Dose Escalation Data from Ongoing Phase 1 KisMET-01 Study of MYTX-011 Texto duplicado
H3 ASCO 2024: Adagrasib Shows Statistically Significant Improvement in PFS in KRASG12C-Mutated NSCLC Texto duplicado
H3 ASCO 2024: A More Effective Treatment Combination for Hodgkin Lymphoma Texto duplicado
H3 ASCO 2024: Asciminib – A Safer + More Effective Option for Newly Diagnosed Chronic... Texto duplicado
H3 ASCO 2024: Durable Efficacy of Lorlatinib as a first-line choice in ALK-positive NSCLC n Texto duplicado
H3 ASCO 2024: NATALEE shows Ribociclib Reduces Risk of Cancer Recurrence in Early Breast Cancer Texto duplicado
H3 ASCO 2024: AbbVie to Showcases Robust Solid Tumor Pipeline with New Data from Its... Texto duplicado
H3 ASCO 2024: Bristol Myers Squibb to Present Results from 130 Studies
H3 Encouraging Conversation & Action on Sexual Health and Fertility for Patients Diagnosed with Cancer
H3 Increased Overall Survival Reported for Combination of Durvalumab plus Chemotherapy
H3 Study Shows Positive Results in Treatment of Cervical High-Grade Squamous Intraepithelial Lesion
H3 Immunotherapy After Surgery Improves Survival in Patients with Kidney Cancer
H3 A Global View of Oncology Informatics Texto duplicado
H3 Standardizing Immunophenotyping Research Tools to Improve MDS and the Immune System Texto duplicado
H3 Experts Forecast: Achieving Cancer Health Equity Texto duplicado
H3 The Impact of DCISionRT Versus Clinicopathologic Factors Alone in Predicting Benefit of Radiation Texto duplicado
H3 Forecast 2024: Broadening the Reach of Cancer Vaccines
H3 The Digital Frontier: 5 Ways Oncology Informatics is Enhancing Cancer Care
H3 Remembering Emil “Jay” Freireich—the Man Who Made Vince DeVita a ‘Believer’
H3 Why Were Top HHS Officials? Interviews Thwarted by Their Press Offices?
H3 Jason Moore, PhD: Improving the Lives of Patients through Computing Technologies and Data Resources
H3 SonALAsense: Developing a Safe and Effective Noninvasive Treatment for Cancer
H3 Be The Match®: Improving Outcomes and Providing Hope to Patients in Need
H3 Solutions to Identify Patients for Recruitment in Early Oncology Clinical Trials Texto duplicado
H3 Crofelemer Reduces Diarrhea in Humans and Dogs Being Treated for Cancer, Recent Studies Show Texto duplicado
H3 Study Shows New Co-Star Receptor to be Promising in Cancer Treatment Texto duplicado
H3 Daiichi Sankyo Out-Licenses Investigational Agent DS-6051 to AnHeart Therapeutics
H3 How Meaningful Will Changes Be to Ethical Guidelines Following Jose Baselga’s Fall?
H3 Reversal of Fortune: How a Vilified Drug Became a Life-saving Agent in the ‘War’...
H4 FEATURED
H4 NEWS
H4 CONFERENCE COVERAGE
H4 EDITORIAL
H4 ERIC ROSENTHAL REPORTS
H4 EXPERT INTERVIEWS
Algunos textos ancla se repiten más de una vez en varios enlaces.
La cantidad de enlaces internos es adecuada.
Ningún texto ancla es excesivamente largo.
Ningún enlace interno contiene parámetros dinámicos.
Hay demasiados enlaces externos (75) en esta página.

Enlaces detectados en esta página

EnlacePropiedadesTexto ancla
https://www.facebook.com/oncoz...Nueva ventana Externo Subdominio A-TITLE Facebook
https://www.linkedin.com/showc...Nueva ventana Externo Subdominio A-TITLE Linkedin
https://soundcloud.com/hofreyNueva ventana Externo A-TITLE Soundcloud
https://twitter.com/OncoZineNueva ventana Externo A-TITLE Twitter
https://vimeo.com/channels/877242Nueva ventana Externo A-TITLE Vimeo
https://www.youtube.com/channe...Nueva ventana Externo Subdominio A-TITLE Youtube
https://www.xing.com/communiti...Nueva ventana Externo Subdominio A-TITLE Xing
https://www.oncozine.com/Subdominio Home
/advertisement-sponsorship-opt...Subdominio Advertisement & Sponsorship Options
https://lp.constantcontactpage...Externo Subdominio Download Our Media Kit
/continued-medical-education-cme/Subdominio Changing Physician Behavior
/cancer-information-by-disease/Subdominio Cancer A – Z
http://www.oncozine.com/Subdominio Drug Developmemt Technologies
/a-novel-technology-based-on-s...Subdominio A Novel Technology based on Somatic Hypermutation (SHM)
/about-oncozine/advisory-board-3/Subdominio Editorial Advisory Board
/join-our-editorial-advisory-b...Subdominio Join Our Editorial Advisory Board
/contact-us/Subdominio Contact Us
/terms-and-conditions/Subdominio Terms and Conditions
/sabcs-and-ash-2023/Subdominio SABCS and ASH 2023
http://www.adcreview.com/Externo Subdominio ADC Review | J. Antibody-drug Conjugates
https://www.adcreview.com/reso...Externo Subdominio Resources for For Clinicians
https://www.adcreview.com/adc-...Externo Subdominio Drug Map (ADC)
https://www.adcreview.com/cate...Externo Subdominio Peer Review Articles
https://www.adcreview.com/the-...Externo Subdominio The Review
/changing-strategies-in-the-wa...Subdominio Changing Strategies in the War on Cancer
/changing-strategies-in-the-wa...Subdominio Changing Strategies in the War on Cancer – Episode 1
/changing-strategies-in-the-wa...Subdominio Changing Strategies in the War on Cancer – Episode 2
/changing-strategies-in-the-wa...Subdominio Changing Strategies in the War on Cancer – Episode 3
/centers-of-the-cancer-univers...Subdominio Centers of the Cancer Universe: A Half-Century of Progress Against Cancer
http://cartcelljournal.com/Externo Journal of CAR T-Cell Therapy
http://cartcelljournal.com/about/Externo About CAR T-cells
http://cartcelljournal.com/faq/Externo Frequently Asked Questions
http://cartcelljournal.com/art...Externo Types of Articles
http://cartcelljournal.com/for...Externo Submit a Manuscript
/the_oncozine_brief_episodes/Subdominio The Onco’Zine Brief
/the_oncozine_brief_episodes/Subdominio The Network
/the-oncozine-brief-episodes/Subdominio The Episodes
https://www.patreon.com/theonc...Nueva ventana Externo Subdominio How to Support The Onco’Zine Brief
/underwriting/Subdominio Corporate Underwriting and Sponsorship
/the-oncozine-dossier/Subdominio The Onco’Zine Dossier
/thalidomide-a-history/Subdominio Thalidomide: A History
/thalidomide-in-the-shadow-of-...Subdominio Thalidomide: In the Shadow of Death
/controversy-the-involvement-o...Subdominio Controversy: The involvement of Ciba AG in the development of Thalidomide
/thalidomides-secret-past-the-...Subdominio Thalidomide’s Secret Past: The Link with Nazi Germany
/reversal-of-fortune-how-a-vil...Subdominio Reversal of Fortune: How a Vilified Drug Became a Life-saving Agent in the ‘War’ Against Cancer
/oncozine-dossier-50-years-aft...Subdominio Smoking and Health
/new-surgeon-generals-report-p...Subdominio New Surgeon General’s Report Presents the Unfiltered Truth About Tobacco
/smoking-and-the-lost-legacy-o...Subdominio Smoking and the Lost Legacy of the First Surgeon General’s Report on Smoking and Health
/tobacco-control-in-the-united...Subdominio Tobacco Control in the United States Has Saved 8 Million Lives In Last 50 Years
http://.com/tobacco-companies-...Externo Tobacco Companies are Finally Moving Closer to Revealing the Truth about Smoking
/the-harmful-effects-of-smokin...Subdominio The Harmful Effects of Smoking: The Public Denial in the Early-mid 1960s
/oncozine.com/oncology-hematol...Subdominio Drug Approvals 2017 – 2020
/oncology-hematology-drug-appr...Subdominio Oncology & Hematology – FDA Drug Approvals 2018
/oncology-hematology-fda-drug-...Subdominio Oncology & Hematology – FDA Drug Approvals 2019
/oncology-hematology-fda-drug-...Subdominio Oncology & Hematology – FDA Drug Approvals 2020
/category/articles/Subdominio Articles
/category/latest-articles/Subdominio Latest Articles
/category/expert-interviews/Subdominio Expert Interviews
/category/editorial-and-commen...Subdominio Editorials and Commentaries
/category/eric-rosenthal-reports/Subdominio Eric Rosenthal Reports
/category/publications-peer-re...Subdominio Publications
/category/news/Subdominio News
/category/business-economics/Subdominio Business & Economics
/category/clinical-development/Subdominio Clinical Development
/category/conference-coverage/Subdominio Conference Coverage
/the_oncozine_brief_episodes/Subdominio Texto duplicado The Onco’Zine Brief
/the-oncozine-brief-episodes/Subdominio Texto duplicado The Episodes
/the-oncozine-brief-national-a...Subdominio National Advertising
http://www.oncozine.com/Nueva ventana Subdominio Resources
https://www.oncologydirectory....Nueva ventana Externo Subdominio Membership
https://www.oncologydirectory....Externo Subdominio Agenda
https://www.oncologydirectory....Nueva ventana Externo Subdominio Join Today
https://www.oncologydirectory....Nueva ventana Externo Subdominio Video
/job-openings/Subdominio Careers
/about-oncozine/about-oncozine-2/Subdominio About
/about-oncozine/advertise-with...Subdominio Advertise
/about-oncozine/advisory-board...Subdominio Advisory Board
/contact-us/Subdominio Texto duplicado Contact Us
https://www.facebook.com/oncoz...Nueva ventana Externo Subdominio Texto duplicado A-TITLE Facebook
https://www.linkedin.com/showc...Nueva ventana Externo Subdominio Texto duplicado A-TITLE Linkedin
https://soundcloud.com/hofreyNueva ventana Externo Texto duplicado A-TITLE Soundcloud
https://twitter.com/OncoZineNueva ventana Externo Texto duplicado A-TITLE Twitter
https://vimeo.com/channels/877242Nueva ventana Externo Texto duplicado A-TITLE Vimeo
https://www.youtube.com/channe...Nueva ventana Externo Subdominio Texto duplicado A-TITLE Youtube
https://www.xing.com/communiti...Nueva ventana Externo Subdominio Texto duplicado A-TITLE Xing
https://www.oncozine.com/Subdominio Onco'Zine
IMG-ALT OncoZine, The International Oncology Network
https://www.oncozine.com/Subdominio IMG-ALT OncoZine, The International Oncology Network
https://www.oncozine.com/Subdominio Texto duplicado IMG-ALT OncoZine, The International Oncology Network
https://www.oncozine.com/Subdominio Texto duplicado Home
/advertisement-sponsorship-opt...Subdominio Texto duplicado Advertisement & Sponsorship Options
https://lp.constantcontactpage...Externo Subdominio Texto duplicado Download Our Media Kit
/continued-medical-education-cme/Subdominio Texto duplicado Changing Physician Behavior
/cancer-information-by-disease/Subdominio Texto duplicado Cancer A – Z
http://www.oncozine.com/Subdominio Texto duplicado Drug Developmemt Technologies
/a-novel-technology-based-on-s...Subdominio Texto duplicado A Novel Technology based on Somatic Hypermutation (SHM)
/about-oncozine/advisory-board-3/Subdominio Texto duplicado Editorial Advisory Board
/join-our-editorial-advisory-b...Subdominio Texto duplicado Join Our Editorial Advisory Board
/contact-us/Subdominio Texto duplicado Contact Us
/terms-and-conditions/Subdominio Texto duplicado Terms and Conditions
/sabcs-and-ash-2023/Subdominio Texto duplicado SABCS and ASH 2023
http://www.adcreview.com/Externo Subdominio Texto duplicado ADC Review | J. Antibody-drug Conjugates
https://www.adcreview.com/reso...Externo Subdominio Texto duplicado Resources for For Clinicians
https://www.adcreview.com/adc-...Externo Subdominio Texto duplicado Drug Map (ADC)
https://www.adcreview.com/cate...Externo Subdominio Texto duplicado Peer Review Articles
https://www.adcreview.com/the-...Externo Subdominio Texto duplicado The Review
/changing-strategies-in-the-wa...Subdominio Texto duplicado Changing Strategies in the War on Cancer
/changing-strategies-in-the-wa...Subdominio Texto duplicado Changing Strategies in the War on Cancer – Episode 1
/changing-strategies-in-the-wa...Subdominio Texto duplicado Changing Strategies in the War on Cancer – Episode 2
/changing-strategies-in-the-wa...Subdominio Texto duplicado Changing Strategies in the War on Cancer – Episode 3
/centers-of-the-cancer-univers...Subdominio Texto duplicado Centers of the Cancer Universe: A Half-Century of Progress Against Cancer
http://cartcelljournal.com/Externo Texto duplicado Journal of CAR T-Cell Therapy
http://cartcelljournal.com/about/Externo Texto duplicado About CAR T-cells
http://cartcelljournal.com/faq/Externo Texto duplicado Frequently Asked Questions
http://cartcelljournal.com/art...Externo Texto duplicado Types of Articles
http://cartcelljournal.com/for...Externo Texto duplicado Submit a Manuscript
/the_oncozine_brief_episodes/Subdominio Texto duplicado The Onco’Zine Brief
/the_oncozine_brief_episodes/Subdominio Texto duplicado The Network
/the-oncozine-brief-episodes/Subdominio Texto duplicado The Episodes
https://www.patreon.com/theonc...Nueva ventana Externo Subdominio Texto duplicado How to Support The Onco’Zine Brief
/underwriting/Subdominio Texto duplicado Corporate Underwriting and Sponsorship
/the-oncozine-dossier/Subdominio Texto duplicado The Onco’Zine Dossier
/thalidomide-a-history/Subdominio Texto duplicado Thalidomide: A History
/thalidomide-in-the-shadow-of-...Subdominio Texto duplicado Thalidomide: In the Shadow of Death
/controversy-the-involvement-o...Subdominio Texto duplicado Controversy: The involvement of Ciba AG in the development of Thalidomide
/thalidomides-secret-past-the-...Subdominio Texto duplicado Thalidomide’s Secret Past: The Link with Nazi Germany
/reversal-of-fortune-how-a-vil...Subdominio Texto duplicado Reversal of Fortune: How a Vilified Drug Became a Life-saving Agent in the ‘War’ Against Cancer
/oncozine-dossier-50-years-aft...Subdominio Texto duplicado Smoking and Health
/new-surgeon-generals-report-p...Subdominio Texto duplicado New Surgeon General’s Report Presents the Unfiltered Truth About Tobacco
/smoking-and-the-lost-legacy-o...Subdominio Texto duplicado Smoking and the Lost Legacy of the First Surgeon General’s Report on Smoking and Health
/tobacco-control-in-the-united...Subdominio Texto duplicado Tobacco Control in the United States Has Saved 8 Million Lives In Last 50 Years
http://.com/tobacco-companies-...Externo Texto duplicado Tobacco Companies are Finally Moving Closer to Revealing the Truth about Smoking
/the-harmful-effects-of-smokin...Subdominio Texto duplicado The Harmful Effects of Smoking: The Public Denial in the Early-mid 1960s
/oncozine.com/oncology-hematol...Subdominio Texto duplicado Drug Approvals 2017 – 2020
/oncology-hematology-drug-appr...Subdominio Texto duplicado Oncology & Hematology – FDA Drug Approvals 2018
/oncology-hematology-fda-drug-...Subdominio Texto duplicado Oncology & Hematology – FDA Drug Approvals 2019
/oncology-hematology-fda-drug-...Subdominio Texto duplicado Oncology & Hematology – FDA Drug Approvals 2020
/category/articles/Subdominio Texto duplicado Articles
/category/latest-articles/Subdominio Texto duplicado Latest Articles
/category/expert-interviews/Subdominio Texto duplicado Expert Interviews
/category/editorial-and-commen...Subdominio Texto duplicado Editorials and Commentaries
/category/eric-rosenthal-reports/Subdominio Texto duplicado Eric Rosenthal Reports
/category/publications-peer-re...Subdominio Texto duplicado Publications
/category/news/Subdominio Texto duplicado News
/category/business-economics/Subdominio Texto duplicado Business & Economics
/category/clinical-development/Subdominio Texto duplicado Clinical Development
/category/conference-coverage/Subdominio Texto duplicado Conference Coverage
/the_oncozine_brief_episodes/Subdominio Texto duplicado The Onco’Zine Brief
/the-oncozine-brief-episodes/Subdominio Texto duplicado The Episodes
/the-oncozine-brief-national-a...Subdominio Texto duplicado National Advertising
http://www.oncozine.com/Nueva ventana Subdominio Texto duplicado Resources
https://www.oncologydirectory....Nueva ventana Externo Subdominio Texto duplicado Membership
https://www.oncologydirectory....Externo Subdominio Texto duplicado Agenda
https://www.oncologydirectory....Nueva ventana Externo Subdominio Texto duplicado Join Today
https://www.oncologydirectory....Nueva ventana Externo Subdominio Texto duplicado Video
/job-openings/Subdominio Texto duplicado Careers
/solutions-to-identify-patient...Subdominio A-TITLE Solutions to Identify Patients for Recruitment in Early Oncology Clinical Trials
/solutions-to-identify-patient...Subdominio Texto duplicado Solutions to Identify Patients for Recruitment in Early Oncology Clinical Trials
A-TITLE Solutions to Identify Patients for Recruitment in Early Oncology Clinical Trials
/author/kimberly_futch_001_bs-...Subdominio Kimberly Futch
/crofelemer-reduces-diarrhea-i...Subdominio A-TITLE Crofelemer Reduces Diarrhea in Humans and Dogs Being Treated for Cancer, Recent Studies Show
/crofelemer-reduces-diarrhea-i...Subdominio Texto duplicado Crofelemer Reduces Diarrhea in Humans and Dogs Being Treated for Cancer, Recent Studies Show
A-TITLE Crofelemer Reduces Diarrhea in Humans and Dogs Being Treated for Cancer, Recent Studies Show
/study-shows-new-co-star-recep...Subdominio A-TITLE Study Shows New Co-Star Receptor to be Promising in Cancer Treatment
/study-shows-new-co-star-recep...Subdominio Texto duplicado Study Shows New Co-Star Receptor to be Promising in Cancer Treatment
A-TITLE Study Shows New Co-Star Receptor to be Promising in Cancer Treatment
/the-concierge-catch-better-ac...Subdominio A-TITLE The Concierge Catch: Better Access for a Few Patients Disrupts Care for Many
/the-concierge-catch-better-ac...Subdominio Texto duplicado The Concierge Catch: Better Access for a Few Patients Disrupts Care for Many
A-TITLE The Concierge Catch: Better Access for a Few Patients Disrupts Care for Many
/asco-2024-encouraging-dose-es...Subdominio A-TITLE ASCO 2024: Encouraging Dose Escalation Data from Ongoing Phase 1 KisMET-01 Study of MYTX-011
/asco-2024-encouraging-dose-es...Subdominio Texto duplicado ASCO 2024: Encouraging Dose Escalation Data from Ongoing Phase 1 KisMET-01 Study of MYTX-011
A-TITLE ASCO 2024: Encouraging Dose Escalation Data from Ongoing Phase 1 KisMET-01 Study of MYTX-011
/category/featured/Subdominio FEATURED
/solutions-to-identify-patient...Subdominio Texto duplicado Solutions to Identify Patients for Recruitment in Early Oncology Clinical Trials
A-TITLE Solutions to Identify Patients for Recruitment in Early Oncology Clinical Trials
/author/kimberly_futch_001_bs-...Subdominio Texto duplicado Kimberly Futch
/crofelemer-reduces-diarrhea-i...Subdominio Texto duplicado Crofelemer Reduces Diarrhea in Humans and Dogs Being Treated for Cancer, Recent Studies Show
A-TITLE Crofelemer Reduces Diarrhea in Humans and Dogs Being Treated for Cancer, Recent Studies Show
/author/okhuysen_pc-001/Subdominio Pablo C. Okhuysen, M.D., FACP, FIDSA
/the-concierge-catch-better-ac...Subdominio Texto duplicado The Concierge Catch: Better Access for a Few Patients Disrupts Care for Many
A-TITLE The Concierge Catch: Better Access for a Few Patients Disrupts Care for Many
/author/john-rossheim_001a/Subdominio John Rossheim
/the-transformative-potential-...Subdominio The Transformative Potential of Exosome Research in Cancer Detection and Beyond
A-TITLE The Transformative Potential of Exosome Research in Cancer Detection and Beyond
/author/biological_d-hdhani_001/Subdominio Harmeet Dhani, MD, MSc
/a-global-view-of-oncology-inf...Subdominio A Global View of Oncology Informatics
A-TITLE A Global View of Oncology Informatics
/author/maria_dolores-mata-moy...Subdominio María Dolores de la Mata Moya
/standardizing-immunophenotypi...Subdominio Standardizing Immunophenotyping Research Tools to Improve MDS and the Immune System
A-TITLE Standardizing Immunophenotyping Research Tools to Improve MDS and the Immune System
/author/leonardo_beretta_001-ad/Subdominio Leonardo Beretta
/experts-forecast-achieving-ca...Subdominio Experts Forecast: Achieving Cancer Health Equity
A-TITLE Experts Forecast: Achieving Cancer Health Equity
/author/neha_j_pancholi_001/Subdominio Neha J. Pancholi, PhD
/the-impact-of-dcisionrt-versu...Subdominio The Impact of DCISionRT Versus Clinicopathologic Factors Alone in Predicting Benefit of Radiation
A-TITLE The Impact of DCISionRT Versus Clinicopathologic Factors Alone in Predicting Benefit of Radiation
/author/amishi-bajaj-001/Subdominio Amishi Bajaj, MD
/category/newsSubdominio NEWS
/solutions-to-identify-patient...Subdominio Texto duplicado Solutions to Identify Patients for Recruitment in Early Oncology Clinical Trials
A-TITLE Solutions to Identify Patients for Recruitment in Early Oncology Clinical Trials
/author/kimberly_futch_001_bs-...Subdominio Texto duplicado Kimberly Futch
/crofelemer-reduces-diarrhea-i...Subdominio Texto duplicado Crofelemer Reduces Diarrhea in Humans and Dogs Being Treated for Cancer, Recent Studies Show
A-TITLE Crofelemer Reduces Diarrhea in Humans and Dogs Being Treated for Cancer, Recent Studies Show
/author/okhuysen_pc-001/Subdominio Texto duplicado Pablo C. Okhuysen, M.D., FACP, FIDSA
/study-shows-new-co-star-recep...Subdominio Texto duplicado Study Shows New Co-Star Receptor to be Promising in Cancer Treatment
A-TITLE Study Shows New Co-Star Receptor to be Promising in Cancer Treatment
/author/peter-hofland/Subdominio Peter Hofland
/the-concierge-catch-better-ac...Subdominio Texto duplicado The Concierge Catch: Better Access for a Few Patients Disrupts Care for Many
A-TITLE The Concierge Catch: Better Access for a Few Patients Disrupts Care for Many
/author/john-rossheim_001a/Subdominio Texto duplicado John Rossheim
/asco-2024-encouraging-dose-es...Subdominio Texto duplicado ASCO 2024: Encouraging Dose Escalation Data from Ongoing Phase 1 KisMET-01 Study of MYTX-011
A-TITLE ASCO 2024: Encouraging Dose Escalation Data from Ongoing Phase 1 KisMET-01 Study of MYTX-011
/author/editorial_team/Subdominio Editorial Team
/asco-2024-adagrasib-shows-sta...Subdominio ASCO 2024: Adagrasib Shows Statistically Significant Improvement in PFS in KRASG12C-Mutated NSCLC
A-TITLE ASCO 2024: Adagrasib Shows Statistically Significant Improvement in PFS in KRASG12C-Mutated NSCLC
/author/editorial_team/Subdominio Texto duplicado Editorial Team
/asco-2024-a-more-effective-tr...Subdominio ASCO 2024: A More Effective Treatment Combination for Hodgkin Lymphoma
A-TITLE ASCO 2024: A More Effective Treatment Combination for Hodgkin Lymphoma
/author/editorial_team/Subdominio Texto duplicado Editorial Team
/asco-2024-asciminib-a-safer-m...Subdominio ASCO 2024: Asciminib – A Safer + More Effective Option for Newly Diagnosed Chronic...
A-TITLE ASCO 2024: Asciminib – A Safer + More Effective Option for Newly Diagnosed Chronic Myeloid Leukemia
/author/editorial_team/Subdominio Texto duplicado Editorial Team
/asco-2024-durable-efficacy-of...Subdominio ASCO 2024: Durable Efficacy of Lorlatinib as a first-line choice in ALK-positive NSCLC n
A-TITLE ASCO 2024: Durable Efficacy of Lorlatinib as a first-line choice in ALK-positive NSCLC n
/author/editorial_team/Subdominio Texto duplicado Editorial Team
/asco-2024-natalee-shows-riboc...Subdominio ASCO 2024: NATALEE shows Ribociclib Reduces Risk of Cancer Recurrence in Early Breast Cancer
A-TITLE ASCO 2024: NATALEE shows Ribociclib Reduces Risk of Cancer Recurrence in Early Breast Cancer
/author/editorial_team/Subdominio Texto duplicado Editorial Team
/asco-2024-abbvie-to-showcases...Subdominio ASCO 2024: AbbVie to Showcases Robust Solid Tumor Pipeline with New Data from Its...
A-TITLE ASCO 2024: AbbVie to Showcases Robust Solid Tumor Pipeline with New Data from Its ADC Platform
/author/editorial_team/Subdominio Texto duplicado Editorial Team
/strong-immunology-portfolio-h...Subdominio Strong Immunology Portfolio helps Offset losses of AbbVie’s Adalimumab
A-TITLE Strong Immunology Portfolio helps Offset losses of AbbVie’s Adalimumab
/author/editorial_team/Subdominio Texto duplicado Editorial Team
/asco-2024-encouraging-dose-es...Subdominio Texto duplicado ASCO 2024: Encouraging Dose Escalation Data from Ongoing Phase 1 KisMET-01 Study of MYTX-011
A-TITLE ASCO 2024: Encouraging Dose Escalation Data from Ongoing Phase 1 KisMET-01 Study of MYTX-011
/author/editorial_team/Subdominio Texto duplicado Editorial Team
/asco-2024-adagrasib-shows-sta...Subdominio Texto duplicado ASCO 2024: Adagrasib Shows Statistically Significant Improvement in PFS in KRASG12C-Mutated NSCLC
A-TITLE ASCO 2024: Adagrasib Shows Statistically Significant Improvement in PFS in KRASG12C-Mutated NSCLC
/author/editorial_team/Subdominio Texto duplicado Editorial Team
/asco-2024-a-more-effective-tr...Subdominio Texto duplicado ASCO 2024: A More Effective Treatment Combination for Hodgkin Lymphoma
A-TITLE ASCO 2024: A More Effective Treatment Combination for Hodgkin Lymphoma
/author/editorial_team/Subdominio Texto duplicado Editorial Team
/asco-2024-asciminib-a-safer-m...Subdominio Texto duplicado ASCO 2024: Asciminib – A Safer + More Effective Option for Newly Diagnosed Chronic...
A-TITLE ASCO 2024: Asciminib – A Safer + More Effective Option for Newly Diagnosed Chronic Myeloid Leukemia
/author/editorial_team/Subdominio Texto duplicado Editorial Team
/asco-2024-durable-efficacy-of...Subdominio Texto duplicado ASCO 2024: Durable Efficacy of Lorlatinib as a first-line choice in ALK-positive NSCLC n
A-TITLE ASCO 2024: Durable Efficacy of Lorlatinib as a first-line choice in ALK-positive NSCLC n
/author/editorial_team/Subdominio Texto duplicado Editorial Team
/asco-2024-natalee-shows-riboc...Subdominio Texto duplicado ASCO 2024: NATALEE shows Ribociclib Reduces Risk of Cancer Recurrence in Early Breast Cancer
A-TITLE ASCO 2024: NATALEE shows Ribociclib Reduces Risk of Cancer Recurrence in Early Breast Cancer
/author/editorial_team/Subdominio Texto duplicado Editorial Team
/asco-2024-abbvie-to-showcases...Subdominio Texto duplicado ASCO 2024: AbbVie to Showcases Robust Solid Tumor Pipeline with New Data from Its...
A-TITLE ASCO 2024: AbbVie to Showcases Robust Solid Tumor Pipeline with New Data from Its ADC Platform
/author/editorial_team/Subdominio Texto duplicado Editorial Team
/asco-2024-bristol-myers-squib...Subdominio ASCO 2024: Bristol Myers Squibb to Present Results from 130 Studies
A-TITLE ASCO 2024: Bristol Myers Squibb to Present Results from 130 Studies
/author/editorial_team/Subdominio Texto duplicado Editorial Team
/encouraging-conversation-acti...Subdominio Encouraging Conversation & Action on Sexual Health and Fertility for Patients Diagnosed with Cancer
A-TITLE Encouraging Conversation & Action on Sexual Health and Fertility for Patients Diagnosed with Cancer
/author/editorial_team/Subdominio Texto duplicado Editorial Team
/increased-overall-survival-re...Subdominio Increased Overall Survival Reported for Combination of Durvalumab plus Chemotherapy
A-TITLE Increased Overall Survival Reported for Combination of Durvalumab plus Chemotherapy
/author/peter-hofland/Subdominio Texto duplicado Peter Hofland
/study-shows-positive-results-...Subdominio Study Shows Positive Results in Treatment of Cervical High-Grade Squamous Intraepithelial Lesion
A-TITLE Study Shows Positive Results in Treatment of Cervical High-Grade Squamous Intraepithelial Lesion
/author/editorial_team/Subdominio Texto duplicado Editorial Team
/immunotherapy-after-surgery-i...Subdominio Immunotherapy After Surgery Improves Survival in Patients with Kidney Cancer
A-TITLE Immunotherapy After Surgery Improves Survival in Patients with Kidney Cancer
/author/editorial_team/Subdominio Texto duplicado Editorial Team
/category/editorial/Subdominio EDITORIAL
/a-global-view-of-oncology-inf...Subdominio Texto duplicado A Global View of Oncology Informatics
A-TITLE A Global View of Oncology Informatics
/author/maria_dolores-mata-moy...Subdominio Texto duplicado María Dolores de la Mata Moya
/standardizing-immunophenotypi...Subdominio Texto duplicado Standardizing Immunophenotyping Research Tools to Improve MDS and the Immune System
A-TITLE Standardizing Immunophenotyping Research Tools to Improve MDS and the Immune System
/author/leonardo_beretta_001-ad/Subdominio Texto duplicado Leonardo Beretta
/experts-forecast-achieving-ca...Subdominio Texto duplicado Experts Forecast: Achieving Cancer Health Equity
A-TITLE Experts Forecast: Achieving Cancer Health Equity
/author/neha_j_pancholi_001/Subdominio Texto duplicado Neha J. Pancholi, PhD
/the-impact-of-dcisionrt-versu...Subdominio Texto duplicado The Impact of DCISionRT Versus Clinicopathologic Factors Alone in Predicting Benefit of Radiation
A-TITLE The Impact of DCISionRT Versus Clinicopathologic Factors Alone in Predicting Benefit of Radiation
/author/amishi-bajaj-001/Subdominio Texto duplicado Amishi Bajaj, MD
/forecast-2024-broadening-the-...Subdominio Forecast 2024: Broadening the Reach of Cancer Vaccines
A-TITLE Forecast 2024: Broadening the Reach of Cancer Vaccines
/author/neha_j_pancholi_001/Subdominio Texto duplicado Neha J. Pancholi, PhD
/the-digital-frontier-5-ways-o...Subdominio The Digital Frontier: 5 Ways Oncology Informatics is Enhancing Cancer Care
A-TITLE The Digital Frontier: 5 Ways Oncology Informatics is Enhancing Cancer Care
/author/jesse-kaestner-001/Subdominio Jesse Kaestner
/category/eric-rosenthal-reports/Subdominio ERIC ROSENTHAL REPORTS
/remembering-emil-jay-freireic...Subdominio Remembering Emil “Jay” Freireich—the Man Who Made Vince DeVita a ‘Believer’
A-TITLE Remembering Emil “Jay” Freireich—the Man Who Made Vince DeVita a ‘Believer’
/author/erictrosenthal/Subdominio Eric T. Rosenthal
/why-were-top-hhs-officials-in...Subdominio Why Were Top HHS Officials? Interviews Thwarted by Their Press Offices?
A-TITLE Why Were Top HHS Officials? Interviews Thwarted by Their Press Offices?
/author/erictrosenthal/Subdominio Texto duplicado Eric T. Rosenthal
/category/expert-interviews/Subdominio EXPERT INTERVIEWS
/jason-moore-phd-improving-the...Subdominio Jason Moore, PhD: Improving the Lives of Patients through Computing Technologies and Data Resources
A-TITLE Jason Moore, PhD: Improving the Lives of Patients through Computing Technologies and Data Resources
/author/editorial_team/Subdominio Texto duplicado Editorial Team
/sonalasense-developing-a-safe...Subdominio SonALAsense: Developing a Safe and Effective Noninvasive Treatment for Cancer
A-TITLE SonALAsense: Developing a Safe and Effective Noninvasive Treatment for Cancer
/author/danielle_garcia/Subdominio Danielle Garcia
/be-the-match-improving-outcom...Subdominio Be The Match®: Improving Outcomes and Providing Hope to Patients in Need
A-TITLE Be The Match®: Improving Outcomes and Providing Hope to Patients in Need
/author/danielle_garcia/Subdominio Texto duplicado Danielle Garcia
/the-oncozine-brief-episodes/Subdominio IMG-ALT spot_img
https://amzn.to/378W1I6Externo Texto duplicado IMG-ALT spot_img
https://amzn.to/3Z0DFEUExterno Texto duplicado IMG-ALT spot_img
/solutions-to-identify-patient...Subdominio Texto duplicado Solutions to Identify Patients for Recruitment in Early Oncology Clinical Trials
A-TITLE Solutions to Identify Patients for Recruitment in Early Oncology Clinical Trials
/author/kimberly_futch_001_bs-...Subdominio Texto duplicado Kimberly Futch
/crofelemer-reduces-diarrhea-i...Subdominio Texto duplicado Crofelemer Reduces Diarrhea in Humans and Dogs Being Treated for Cancer, Recent Studies Show
A-TITLE Crofelemer Reduces Diarrhea in Humans and Dogs Being Treated for Cancer, Recent Studies Show
/author/okhuysen_pc-001/Subdominio Texto duplicado Pablo C. Okhuysen, M.D., FACP, FIDSA
/study-shows-new-co-star-recep...Subdominio Texto duplicado Study Shows New Co-Star Receptor to be Promising in Cancer Treatment
A-TITLE Study Shows New Co-Star Receptor to be Promising in Cancer Treatment
/author/peter-hofland/Subdominio Texto duplicado Peter Hofland
/daiichi-sankyo-out-licenses-i...Subdominio Daiichi Sankyo Out-Licenses Investigational Agent DS-6051 to AnHeart Therapeutics
A-TITLE Daiichi Sankyo Out-Licenses Investigational Agent DS-6051 to AnHeart Therapeutics
/author/peter-hofland/Subdominio Texto duplicado Peter Hofland
/how-meaningful-will-changes-b...Subdominio How Meaningful Will Changes Be to Ethical Guidelines Following Jose Baselga’s Fall?
A-TITLE How Meaningful Will Changes Be to Ethical Guidelines Following Jose Baselga’s Fall?
/author/erictrosenthal/Subdominio Texto duplicado Eric T. Rosenthal
/reversal-of-fortune-how-a-vil...Subdominio Reversal of Fortune: How a Vilified Drug Became a Life-saving Agent in the ‘War’...
A-TITLE Reversal of Fortune: How a Vilified Drug Became a Life-saving Agent in the ‘War’ Against Cancer
/author/peter-hofland/Subdominio Texto duplicado Peter Hofland
/category/news/Subdominio News2935
/category/conference-coverage/Subdominio Conference Coverage507
/category/research-and-develop...Subdominio Research & Development364
/category/cancer-risk/Subdominio Cancer Risk304
/category/clinical-trial-updates/Subdominio Clinical Trial Updates277
/category/clinical-development/Subdominio Clinical development271
/category/business-economics/Subdominio Business & Economics197
/category/regulatory-updates/Subdominio Regulatory Updates120
/category/op-ed-opinion/Subdominio Op-Ed | Opinion112
/category/must-read-articles/Subdominio Must Read Articles110
https://www.oncozine.com/Subdominio IMG-ALT Onco\'Zine, The International Oncology Network
https://www.facebook.com/oncoz...Nueva ventana Externo Subdominio Texto duplicado A-TITLE Facebook
https://www.linkedin.com/showc...Nueva ventana Externo Subdominio Texto duplicado A-TITLE Linkedin
https://soundcloud.com/hofreyNueva ventana Externo Texto duplicado A-TITLE Soundcloud
https://twitter.com/OncoZineNueva ventana Externo Texto duplicado A-TITLE Twitter
https://vimeo.com/channels/877242Nueva ventana Externo Texto duplicado A-TITLE Vimeo
https://www.youtube.com/channe...Nueva ventana Externo Subdominio Texto duplicado A-TITLE Youtube
https://www.xing.com/communiti...Nueva ventana Externo Subdominio Texto duplicado A-TITLE Xing
https://www.oncozine.com/Subdominio Texto duplicado Home
/advertisement-sponsorship-opt...Subdominio Texto duplicado Advertisement & Sponsorship Options
https://lp.constantcontactpage...Externo Subdominio Texto duplicado Download Our Media Kit
/continued-medical-education-cme/Subdominio Texto duplicado Changing Physician Behavior
/cancer-information-by-disease/Subdominio Texto duplicado Cancer A – Z
http://www.oncozine.com/Subdominio Texto duplicado Drug Developmemt Technologies
/a-novel-technology-based-on-s...Subdominio Texto duplicado A Novel Technology based on Somatic Hypermutation (SHM)
/about-oncozine/advisory-board-3/Subdominio Texto duplicado Editorial Advisory Board
/join-our-editorial-advisory-b...Subdominio Texto duplicado Join Our Editorial Advisory Board
/contact-us/Subdominio Texto duplicado Contact Us
/terms-and-conditions/Subdominio Texto duplicado Terms and Conditions
/sabcs-and-ash-2023/Subdominio Texto duplicado SABCS and ASH 2023
http://www.adcreview.com/Externo Subdominio Texto duplicado ADC Review | J. Antibody-drug Conjugates
https://www.adcreview.com/reso...Externo Subdominio Texto duplicado Resources for For Clinicians
https://www.adcreview.com/adc-...Externo Subdominio Texto duplicado Drug Map (ADC)
https://www.adcreview.com/cate...Externo Subdominio Texto duplicado Peer Review Articles
https://www.adcreview.com/the-...Externo Subdominio Texto duplicado The Review
/changing-strategies-in-the-wa...Subdominio Texto duplicado Changing Strategies in the War on Cancer
/changing-strategies-in-the-wa...Subdominio Texto duplicado Changing Strategies in the War on Cancer – Episode 1
/changing-strategies-in-the-wa...Subdominio Texto duplicado Changing Strategies in the War on Cancer – Episode 2
/changing-strategies-in-the-wa...Subdominio Texto duplicado Changing Strategies in the War on Cancer – Episode 3
/centers-of-the-cancer-univers...Subdominio Texto duplicado Centers of the Cancer Universe: A Half-Century of Progress Against Cancer
http://cartcelljournal.com/Externo Texto duplicado Journal of CAR T-Cell Therapy
http://cartcelljournal.com/about/Externo Texto duplicado About CAR T-cells
http://cartcelljournal.com/faq/Externo Texto duplicado Frequently Asked Questions
http://cartcelljournal.com/art...Externo Texto duplicado Types of Articles
http://cartcelljournal.com/for...Externo Texto duplicado Submit a Manuscript
/the_oncozine_brief_episodes/Subdominio Texto duplicado The Onco’Zine Brief
/the_oncozine_brief_episodes/Subdominio Texto duplicado The Network
/the-oncozine-brief-episodes/Subdominio Texto duplicado The Episodes
https://www.patreon.com/theonc...Nueva ventana Externo Subdominio Texto duplicado How to Support The Onco’Zine Brief
/underwriting/Subdominio Texto duplicado Corporate Underwriting and Sponsorship
/the-oncozine-dossier/Subdominio Texto duplicado The Onco’Zine Dossier
/thalidomide-a-history/Subdominio Texto duplicado Thalidomide: A History
/thalidomide-in-the-shadow-of-...Subdominio Texto duplicado Thalidomide: In the Shadow of Death
/controversy-the-involvement-o...Subdominio Texto duplicado Controversy: The involvement of Ciba AG in the development of Thalidomide
/thalidomides-secret-past-the-...Subdominio Texto duplicado Thalidomide’s Secret Past: The Link with Nazi Germany
/reversal-of-fortune-how-a-vil...Subdominio Texto duplicado Reversal of Fortune: How a Vilified Drug Became a Life-saving Agent in the ‘War’ Against Cancer
/oncozine-dossier-50-years-aft...Subdominio Texto duplicado Smoking and Health
/new-surgeon-generals-report-p...Subdominio Texto duplicado New Surgeon General’s Report Presents the Unfiltered Truth About Tobacco
/smoking-and-the-lost-legacy-o...Subdominio Texto duplicado Smoking and the Lost Legacy of the First Surgeon General’s Report on Smoking and Health
/tobacco-control-in-the-united...Subdominio Texto duplicado Tobacco Control in the United States Has Saved 8 Million Lives In Last 50 Years
http://.com/tobacco-companies-...Externo Texto duplicado Tobacco Companies are Finally Moving Closer to Revealing the Truth about Smoking
/the-harmful-effects-of-smokin...Subdominio Texto duplicado The Harmful Effects of Smoking: The Public Denial in the Early-mid 1960s
/oncozine.com/oncology-hematol...Subdominio Texto duplicado Drug Approvals 2017 – 2020
/oncology-hematology-drug-appr...Subdominio Texto duplicado Oncology & Hematology – FDA Drug Approvals 2018
/oncology-hematology-fda-drug-...Subdominio Texto duplicado Oncology & Hematology – FDA Drug Approvals 2019
/oncology-hematology-fda-drug-...Subdominio Texto duplicado Oncology & Hematology – FDA Drug Approvals 2020
/category/articles/Subdominio Texto duplicado Articles
/category/latest-articles/Subdominio Texto duplicado Latest Articles
/category/expert-interviews/Subdominio Texto duplicado Expert Interviews
/category/editorial-and-commen...Subdominio Texto duplicado Editorials and Commentaries
/category/eric-rosenthal-reports/Subdominio Texto duplicado Eric Rosenthal Reports
/category/publications-peer-re...Subdominio Texto duplicado Publications
/category/news/Subdominio Texto duplicado News
/category/business-economics/Subdominio Texto duplicado Business & Economics
/category/clinical-development/Subdominio Texto duplicado Clinical Development
/category/conference-coverage/Subdominio Texto duplicado Conference Coverage
/the_oncozine_brief_episodes/Subdominio Texto duplicado The Onco’Zine Brief
/the-oncozine-brief-episodes/Subdominio Texto duplicado The Episodes
/the-oncozine-brief-national-a...Subdominio Texto duplicado National Advertising
http://www.oncozine.com/Nueva ventana Subdominio Texto duplicado Resources
https://www.oncologydirectory....Nueva ventana Externo Subdominio Texto duplicado Membership
https://www.oncologydirectory....Externo Subdominio Texto duplicado Agenda
https://www.oncologydirectory....Nueva ventana Externo Subdominio Texto duplicado Join Today
https://www.oncologydirectory....Nueva ventana Externo Subdominio Texto duplicado Video
/job-openings/Subdominio Texto duplicado Careers
https://lp.constantcontactpage...Nueva ventana Externo Subdominio Sin texto

Configuración del servidor

Redirecciones HTTP
(Extremadamente importante)
Esta página redirige a "https://www.oncozine.com/".
Cabecera HTTP
(Importante)
La cabecera X-Powered-by no se envía en la cabecera de la página.
Esta página utiliza GZip para la transmisión de datos comprimidos.
Rendimiento
(Poco importante)
Con 1,01 segundos, el tiempo de respuesta de la página es superior al límite recomendado de 0,4 segundos. Un tiempo de respuesta elevado ralentiza innecesariamente el rastreo de los buscadores y propicia una mala experiencia de uso.
El tamaño HTML de la página es adecuado: 221 kB.

Cabecera HTTP

NombreValor
servernginx
dateSun, 14 Jul 2024 05:25:10 GMT
content-typetext/html; charset=UTF-8
varyAccept-Encoding
x-cache-enabledTrue
link<https://www.oncozine.com/wp-json/>; rel="https://api.w.org/", <https://www.oncozine.com/wp-json/wp/v2/pages/6893>; rel="alternate"; type="application/json", <https://www.oncozine.com/>; rel=shortlink
x-httpd1
x-cdn-call
content-encodinggzip
x-sg-cdn1
x-proxy-cacheHIT
host-header8441280b0c35cbc1147f8ba998a563a7
statuscode200
http_versionHTTP/2

Factores externos

Listas negras
(Deseable)
Esta página no está clasificada como “contenido para adultos”.
Esta página recibe enlaces de calidad de otros sitios web.
Esta página recibe backlinks de 333 dominios de referencia.
Esta página recibe un total de 1.075 backlinks.
Esta página recibe backlinks de 260 direcciones IP distintas.
Popularidad en Facebook
(Poco importante)
Esta página tiene 0 compartir y comentarios en Facebook.

Backlinks desde Wikipedia

No se ha encontrado ningún enlace lanzado desde la Wikipedia.

Robots.txt

# START WPFORMS BLOCK
# ---------------------------
User-agent: *
Disallow: /wp-content/uploads/wpforms/
# ---------------------------
# END WPFORMS BLOCK

# START YOAST BLOCK
# ---------------------------
User-agent: *
Disallow:

Sitemap: https://www.oncozine.com/sitemap_index.xml
# ---------------------------
# END YOAST BLOCK

Páginas similares

Snippet (vista previa de los resultados de búsqueda)

www.oncozine.com
Home - Onco'Zine - A part of the Oncology and Hematology News ...
Onco'Zine is part of the Oncology and Hematology News Network that has been created to better inform physicians treating patients with cancer

Palabras clave más importantes

Se han encontrado las siguientes palabras clave. Comprueba si esta página está bien optimizada para cada palabra clave en concreto.

Palabra claveResultadoComprobar
Onco95%Check
Onco Zine94%Check
Zine91%Check
Oncology80%Check
Oncology Network78%Check
Network76%Check
Onco Zine Brief75%Check
Oncology Hematology69%Check
News Network69%Check
Hematology News Network65%Check
Mostrar más palabras clave

¡Analiza ya gratis hasta 1.000 páginas de oncozine.com!

Registrarme Gratis
Puedes usar la suscripción Básica por tiempo ilimitado.

Política de cookies

Utilizamos cookies para el buen funcionamiento de nuestra web y con fines analíticos y publicitarios. Puedes activar o desactivar las cookies opcionales. Para más información consulta los siguientes enlaces.

Aviso legal | Privacidad y Cookies

Utilizamos estas cookies para que el sitio funcione correctamente

Con estas cookies podemos entender mejor cómo navegan las y los visitantes por nuestra web

Estas cookies nos ayudan a ofrecerte anuncios y promociones que se ajusten a tus intereses